Think Big Money Is Interested in Anti-Aging?
Big Bucks for Big Promises
In Big Bucks talk (financial jargon)...
There's usually a cool babe on my back. |
What’s bigger than a unicorn? Samumed stuns yet again as anti-aging pipeline draws $438M at $12B valuation
Samumed is a "regenerative medicine" operation in San Diego, working on drugs to keep us young and active (and cute). Their most advanced (through the approval pipeline) drug is for osteoarthritis - mainly in the knees. They have NO PRODUCTS ON THE MARKET yet. Yet they just raised a half billion bucks.
(The "cute" part is their second most advanced drug which cures baldness.)
Their focus is on us the aging (everybody), with human clinical trials of experimental drugs to treat cancer, osteoarthritis, degenerative disc disease, idiopathic pulmonary fibrosis, and several other diseases.
Their one and only venture capitalist backer is Singapore-based Vickers Venture Partners. Chinese! Surprise, surprise. Those Chinese are on a pharma tear.
...and there are several "individually wealthy investors" tossing money into the pot as well.
Like I've noted before, the rich are going all out for anti-aging. (Click here)
On it goes, the search for the Fountain of Youth. Move over, Juan Ponce de Leon. Make room for a few plutocrats and a bunch of Chinese!
(Wikipedia) |
Comments